Funds · RXRX

Who owns RXRX?

Institutional ownership of Recursion Pharmaceuticals Inc. from Form 13F, Q2 2026

343 institutional managers reported holding Recursion Pharmaceuticals Inc. (RXRX) in Form 13F filings for Q2 2026, with 361,990,761 shares worth $1.3B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 25,686,672 shares (+7.6%). 45 opened new positions and 41 sold out.

Funds holding
343
Value held
$1.3B
New / sold out
45 / 41
Net shares, same filers
+7.6%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of RXRX

FundValueShare of 13F holdingsSharesMove
BlackRock, Inc.$185M13.9%50,304,691Added
ARK Investment Management LLC$152M11.4%41,337,632Added
State Street Corp$127M9.6%34,706,130Added
Vanguard Portfolio Management LLC$114M8.6%31,131,599Added
Baillie Gifford & Co$86.2M6.5%23,487,907Trimmed
Vanguard Capital Management LLC$83.6M6.3%22,765,940Added
Geode Capital Management, LLC$50.7M3.8%13,819,135Added
Softbank Group Corp.$50.0M3.8%13,636,515Unchanged
MIC Capital Management UK LLP$35.4M2.7%9,644,033Unchanged
UBS Group AG$32.8M2.5%8,947,102Added
Norges Bank$25.1M1.9%6,833,534New
Data Collective IV GP, LLC$21.8M1.6%5,941,120Unchanged
Amova Asset Management Americas, Inc.$20.2M1.5%5,511,687Added
Sumitomo Mitsui Trust Group, Inc.$20.2M1.5%5,511,687Added
Northern Trust Corp$17.5M1.3%4,758,236Added
Marshall Wace, LLP$17.3M1.3%4,714,577Added
Charles Schwab Investment Management Inc$15.2M1.1%4,138,286Added
DCVC Opportunity Fund II GP, LLC$14.5M1.1%3,951,141Unchanged
Goldman Sachs Group Inc$14.4M1.1%3,917,858Trimmed
Vanguard Fiduciary Trust Co$12.7M1.0%3,470,558Trimmed
Two Sigma Investments, LP$12.3M0.9%3,353,658Trimmed
Susquehanna International Group, LLP$12.1M0.9%3,292,128Trimmed
First Trust Advisors LP$11.2M0.8%3,041,829Added
Morgan Stanley$10.1M0.8%2,743,499Added
IQ EQ FUND MANAGEMENT (IRELAND) Ltd$9.6M0.7%2,604,317Added

Share of 13F holdings is each fund's shares as a share of the 361,990,761 RXRX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $181M and sold $83.0M; 126 added and 99 trimmed.

Schedule 13D and 13G filings on RXRX

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about RXRX ownership

Who owns RXRX stock?
343 institutional investment managers reported RXRX positions in their Form 13F filings for Q2 2026, holding 361,990,761 shares worth $1.3B in total. BlackRock, Inc. reported the largest position.
Are funds buying or selling RXRX?
In Q2 2026, 45 managers opened new RXRX positions, 126 added, 99 trimmed and 41 sold out. Managers that filed in both quarters added a net 25,686,672 shares.
How current is this RXRX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to RXRX by CUSIP. Options are left out. RXRX news and filings · RXRX insider trades · Top funds